Omnigen in Acute Chemical Eye Injuries

NCT05618522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2022-11-16

No results posted yet for this study

Summary

evaluation of the role of Omnigen in acute chemical eye injuries

Conditions

  • Acute Chemical Eye Injuries

Interventions

PROCEDURE

vacuum-dehydrated amnion membrane (omnigen)

applying the lens loaded with Omnigen on the cornea

DEVICE

the lens loaded with Omnigen

the lens loaded with Omnigen

Sponsors & Collaborators

  • Farwaniya Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-07-01
Completion
2022-09-01

Countries

  • Kuwait

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618522 on ClinicalTrials.gov